Nucleoside-modified mRNA vaccines induce potent T follicular helper and germinal center B cell responses

Cited by (531)

Items 301–400 of 531

1. Sibling cases of gross hematuria and newly diagnosed IgA nephropathy following SARS-CoV-2 vaccination
   Yuri Uchiyama, Hirotaka Fukasawa, Yuri Ishino, Daisuke Nakagami, Mai Kaneko, Hideo Yasuda, Ryuichi Furuya · 2022 · BMC Nephrology
2. Current status and patent prospective of lipid nanoparticle for mRNA delivery
   Hailong Zhang · 2023 · Expert Opinion on Therapeutic Patents
3. Impfempfehlungen der Ständigen Impfkommission (STIKO)
   Christian Bogdan · 2021 · Der Hautarzt
4. Optimal murine CD4+ T cell priming by mRNA-lipid nanoparticle vaccines requires endogenous antigen processing
   Julia E. Rood, Suh Kyung Yoon, Mary K. Heard, Stephen D. Carro, Emma J. Hedgepeth, Mary E. O'Mara, Michael J. Hogan, Nhu Le, Hiromi Muramatsu, Kieu Lam et al. · 2026 · Nature Communications
5. Antibody and T-Cell Subsets Analysis Unveils an Immune Profile Heterogeneity Mediating Long-term Responses in Individuals Vaccinated Against SARS-CoV-2
   Maria Agallou, Olga S. Koutsoni, Maria Michail, Paraskevi Zisimopoulou, Ourania Tsitsilonis, Evdokia Karagouni · 2022 · The Journal of Infectious Diseases
6. Determination of significant immunological timescales from mRNA-LNP-based vaccines in humans
   Iain R. Moyles, Chapin S. Korosec, Jane Marie Heffernan · 2023 · Journal of Mathematical Biology
7. A rabies mRNA vaccine provides a rapid and long-term immune response in mice
   Jinrong Long, Changxiao Yu, Yiming Cao, Yiqi Miao, Huisheng Sun, Zhen Zhang, Jierui Mai, Xin Wang, Yingying Mao, Hongwei Li et al. · 2023 · Nano Today
8. The contributions of T cell-mediated immunity to protection from vaccine-preventable diseases: A primer
   Janna R. Shapiro, Mario Corrado, Julie Ann Perry, Tania H. Watts, Shelly Bolotin · 2024 · Human Vaccines & Immunotherapeutics
9. Clinical Development of mRNA Vaccines: Challenges and Opportunities
   Allison August, Luis Brito, Robert Paris, Tal Z. Zaks · 2022 · Current topics in microbiology and immunology
10. COVID-19 vaccines and a perspective on Africa
    Alberto Mantovani, María Rescigno, Guido Forni, Francesca Tognon, Giovanni Putoto, Jerry Ictho, Peter Lochoro · 2023 · Trends in Immunology
11. Allergen-specific mRNA–lipid nanoparticle therapy for prevention and treatment of experimental allergy in mice
    Yrina Rochman, Michael Kotliar, Andrea M. Klingler, Mark Rochman, Mohamad‐Gabriel Alameh, Jilian R. Melamed, Garrett A. Osswald, Julie M. Caldwell, Jennifer M. Felton, Lydia E. Mack et al. · 2025 · Journal of Clinical Investigation
12. Impact of stabilizing mutations on the antigenic profile and glycosylation of membrane-expressed HIV-1 envelope glycoprotein
    Tommy Tong, Alessio D’Addabbo, Jiamin Xu, Himanshi Chawla, Albert Nguyen, Paola Ochoa, Max Crispin, James Μ. Binley · 2023 · PLoS Pathogens
13. Innate and Adaptive Immune Parameters following mRNA Vaccination in Mice
    Srinivasa Reddy Bonam, Nicholas C. Hazell, Mano Joseph Mathew, Yuejin Liang, Xuxiang Zhang, Zhi Wei, Mohamad‐Gabriel Alameh, Drew Weissman, Haitao Hu · 2024 · Vaccines
14. Polymeric cGAMP microparticles affect the immunogenicity of a broadly active influenza mRNA lipid nanoparticle vaccine
    Dylan A. Hendy, Yutian Ma, Timothy A. Dixon, Connor T. Murphy, Erik S. Pena, Michael A. Carlock, Ted M. Ross, Eric M. Bachelder, Kristy M. Ainslie, Owen S. Fenton · 2024 · Journal of Controlled Release
15. Research progress of mosquito-borne virus mRNA vaccines
    Ning Sun, Zhiwei Su, Xiaoyan Zheng · 2024 · Molecular Therapy — Methods & Clinical Development
16. Influenza 5xM2e mRNA lipid nanoparticle vaccine confers broad immunity and significantly enhances the efficacy of inactivated split vaccination when coadministered
    Phillip B Grovenstein, Noopur Bhatnagar, Ki‐Hye Kim, Surya Sekhar Pal, Chau Thuy Tien Le, Jannatul Ruhan Raha, Rong Liu, Chong Hyun Shin, Bo Ryoung Park, Lanying Du et al. · 2025 · The Journal of Immunology
17. Technological breakthroughs and advancements in the application of mRNA vaccines: a comprehensive exploration and future prospects
    Zhimeng Wei, Shuai Zhang, Xingya Wang, Ying Xue, Sheng Dang, Jingbo Zhai · 2025 · Frontiers in Immunology
18. Nanoformulated Single‐Stranded RNA‐Based Adjuvant with a Coordinative Amphiphile as an Effective Stabilizer: Inducing Humoral Immune Response by Activation of Antigen‐Presenting Cells
    Hyo‐Jung Park, Eun‐Kyoung Bang, Jung Joo Hong, Sang‐Myeong Lee, Hae Li Ko, Hye Won Kwak, Hye-Lim Park, Kyung Won Kang, Rhoon‐Ho Kim, Seung Rok Ryu et al. · 2020 · Angewandte Chemie International Edition
19. Biomimetic Nanotechnology for SARS-CoV-2 Treatment
    Shuo Li, Xue Liu, Gang Liu, Chao Liu · 2023 · Viruses
20. COVID-19 mRNA vaccination is associated with IgA nephropathy: an analysis of the Japanese adverse drug event report database
    Hiroka Nakao, Takenao Koseki, Koki Kato, Shigeki Yamada, Naotake Tsuboi, Kazuo Takahashi, Tomohiro Mizuno · 2023 · Journal of Pharmacy & Pharmaceutical Sciences
21. Adjuvanted-SARS-CoV-2 Spike Protein-Based Microparticulate Vaccine Delivered by Dissolving Microneedles Induces Humoral, Mucosal, and Cellular Immune Responses in Mice
    Smital Patil, Sharon Vijayanand, Ipshita Menon, Keegan Braz Gomes, Akanksha Kale, Priyal Bagwe, Shadi Yacoub, Mohammad Nasir Uddin, Martin J. D’Souza · 2023 · Pharmaceuticals
22. Neoantigen mRNA vaccines and A 2 A receptor antagonism: A strategy to enhance T cell immunity
    Saber İmani, Parham Jabbarzadeh Kaboli, Ali Babaeizad, Mazaher Maghsoudloo · 2025 · Human Vaccines & Immunotherapeutics
23. Insights From Early Clinical Trials Assessing Response to mRNA SARS-CoV-2 Vaccination in Immunocompromised Patients
    Frédéric Baron, Lorenzo Canti, Kevin K. Ariën, Delphine Kemlin, Isabelle Desombere, Margaux Gerbaux, Pieter Pannus, Yves P. Beguin, Arnaud Marchant, Stéphanie Humblet‐Baron · 2022 · Frontiers in Immunology
24. Materials‐based vaccines for infectious diseases
    Bo Yang, Hua Wang · 2022 · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology
25. Vaccination against Borna Disease: Overview, Vaccine Virus Characterization and Investigation of Live and Inactivated Vaccines
    Ralf Dürrwald, Jolanta Kolodziejek, Djin‐Ye Oh, Sibylle Herzog, Heinrich Liebermann, Nikolaus Osterrieder, Norbert R. Nowotny · 2022 · Viruses
26. Exploring in vitro expression and immune potency in mice using mRNA encoding the Plasmodium falciparum malaria antigen, CelTOS
    Ishita N. Waghela, Katherine L. Mallory, Justin A. Taylor, Cosette G. Schneider, Tatyana Savransky, Chris J. Janse, Paulo J.C. Lin, Ying K. Tam, Drew Weissman, Evelina Angov · 2022 · Frontiers in Immunology
27. Evaluation of mRNA-1273 against SARS-CoV-2 B.1.351 Infection in Nonhuman Primates
    Kizzmekia S. Corbett, Anne P. Werner, Sarah O’ Connell, Matthew Gagné, Lilin Lai, Juan I. Moliva, Barbara J. Flynn, Angela Choi, Matthew J. Koch, Kathryn E. Foulds et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
28. Influenza virus antibodies inhibit antigen-specific de novo B cell responses in mice
    Eileen C. Goodwin, James S. Gibbs, Jonathan Wilson Yewdell, Laurence Crane Eisenlohr, Scott E. Hensley · 2024 · Journal of Virology
29. Individualized mRNA Vaccines in Melanoma—Where Do We Stand?
    Ioanna Gazouli, Dimitrios I. Bafaloukos, Christos Koutserimpas, George Samonis · 2025 · Vaccines
30. Enhanced B cell priming induces broadly neutralizing HIV-1 apex antibodies
    Lorie Marchitto, Kshitij Wagh, Ryan S. Roark, Séverin Coléon, Hui Li, Ashwin N. Skelly, Michael P. Hogarty, Rumi Habib, Wenge Ding, Kasirajan Ayyanathan et al. · 2026 · Nature
31. RETRACTED: Heterogeneous Longitudinal Antibody Responses to Covid-19 mRNA Vaccination
    Suzanne M. de la Monte, Christine Long, Nicole Szczepanski, Christopher Griffin, A. L. Fitzgerald, Kimberle C. Chapin · 2021 · Clinical Pathology · Retracted
32. New insights into the mucosal immune pathogenesis of IgA nephropathy from the perspective of COVID-19 vaccination
    Yaohui Ma, Yan Huang, Gaosi Xu · 2023 · QJM
33. Multi-phasic gene profiling using candidate gene approach predict the capacity of specific antibody production and maintenance following COVID-19 vaccination in Japanese population
    Yuki Takemoto, Naoki Tanimine, Hisaaki Yoshinaka, Yuka Tanaka, Toshiro Takafuta, Aya Sugiyama, Junko Tanaka, Hideki Ohdan · 2023 · Frontiers in Immunology
34. Evaluation of mRNA-LNP and adjuvanted protein SARS-CoV-2 vaccines in a maternal antibody mouse model
    Ross N. England, Elizabeth M. Drapeau, Mohamad‐Gabriel Alameh, Reihaneh Hosseinzadeh, Drew Weissman, Scott E. Hensley · 2024 · npj Vaccines
35. Parahydrogen‐Induced Polarization of a Labeled, Cancer‐Targeting DNA Aptamer
    Kai‐Oliver Brenske, Meike Emondts, Sven T. Hörnig, Sinan Panitz, Maria I. Pieper, Aron Ligori, Alexander Schacht, Johanna Henkel, Jürgen Klankermayer, Andreas Herrmann · 2023 · Angewandte Chemie International Edition
36. Accelerate Coronavirus Disease 2019 (COVID-19) Vaccine Rollout by Delaying the Second Dose of mRNA Vaccines
    Stanley Alan Plotkin, Neal A. Halsey · 2021 · Clinical Infectious Diseases
37. Optimization of 5′UTR to evade SARS-CoV-2 Nonstructural protein 1-directed inhibition of protein synthesis in cells
    Shih-Cheng Chen, Cui-Ting Xu, Chuan-Fu Chang, Ting-Yu Chao, Chia‐Chi Lin, Pei-Wen Fu, Chien‐Hung Yu · 2023 · Applied Microbiology and Biotechnology
38. The role of mRNA vaccines in infectious diseases: a new era of immunization
    Kesaobaka Batisani · 2025 · Tropical Diseases Travel Medicine and Vaccines
39. Lipid Nanoparticle Development for A Fluvid mRNA Vaccine Targeting Seasonal Influenza and SARS-CoV-2
    Jiin H. Felgner, Jenny E. Hernandez‐Davies, Erwin Strahsburger, Emily K. Silzel, Rie Nakajima, Aarti Jain, Jacob Laster, Jui-Lin Chiang, Ya-Li Tsai, Philip Louis Felgner et al. · 2025 · npj Vaccines
40. mRNA-LNP vaccines against hepatitis B virus induce protective immune responses in preventive and chronic mouse challenge models
    María José Limeres, Rocío Celeste Gambaro, Malin Svensson, Silvia Fraude-El Ghazi, Leah Pretsch, Daniel Frank, German Abel Islan, Ignacio Rivero Berti, Matthias Bros, Ying K. Tam et al. · 2025 · Molecular Therapy
41. Potential of mRNA vaccines to become versatile cancer vaccines
    S.Y. Tsao · 2022 · World Journal of Clinical Oncology
42. Influenza a Neuraminidase-Based Bivalent mRNA Vaccine Induces Th1-Type Immune Response and Provides Protective Effects in Mice
    Mingyang Li, Mengyuan Liu, Shaohui Song, Ruirui Zhao, Yun Xie, Jing Liu, Lilan Xu, Xuefeng Ma, Mingyu Song, Jian Zhou et al. · 2024 · Vaccines
43. Screening lipid nanoparticles using DNA barcoding and qPCR
    Dawei Liu, Xing Wang, Letao Xu, Zahraa Al-Delfi, Zelalem Addis Mekonnen, Song Gao, Branka Grubor‐Bauk, Chun‐Xia Zhao · 2025 · Colloids and Surfaces B Biointerfaces
44. New-Onset Acute Interstitial Nephritis Post-SARS-CoV-2 Infection and COVID-19 Vaccination: A Panoramic Review
    Yu Wang, Ling Yang, Gaosi Xu · 2023 · Journal of Epidemiology and Global Health
45. Kidney complications following COVID-19 vaccination; a review of the literature
    Shakiba Hassanzadeh, Arjang Djamali, Leila Mostafavi, Aiyoub Pezeshgi · 2021 · Journal of Nephropharmacology
46. cGAS mRNA–Based Immune Agonist Promotes Vaccine Responses and Antitumor Immunity
    Yali Qu, Zhibin Li, Jiahao Yin, He Huang, Jialu Ma, Zhelin Jiang, Qian Zhou, Ying Tang, Yuting Li, Minpeng Huang et al. · 2025 · Cancer Immunology Research
47. A systematic and thematic analysis of the top 100 cited articles on mRNA vaccine indexed in Scopus database
    Hassan Hussein Musa, Taha Hussein Musa · 2022 · Human Vaccines & Immunotherapeutics
48. A nucleoside-modified rabies mRNA vaccine induces long-lasting and comprehensive immune responses in mice and non-human primates
    Yu Wang, Shen Wang, Lulu Huang, Wenhao Mao, Fangmeng Li, Ang Lin, Weijun Zhao, Xianhuan Zeng, Yue Zhang, Dingcao Yang et al. · 2024 · Molecular Therapy
49. An immunoinformatics approach in designing high-coverage mRNA multi-epitope vaccine against multivariant SARS-CoV-2
    Ernawati Arifin Giri-Rachman, Al Mirahma Febri Kurnianti, Rizarullah Rizarullah, Aditya Hanung Setyadi, Anita Artarini, Marselina Irasonia Tan, Catur Riani, Dessy Natalia, Reza Aditama, Husna Nugrahapraja · 2025 · Journal of Genetic Engineering and Biotechnology
50. Cyclic Helix B Peptide Prolongs Skin Allograft Survival via Inhibition of B Cell Immune Responses in a Murine Model
    Long Zheng, Xuanchuan Wang, Linkun Hu, Wenjun Gao, Weitao Zhang, Xuepeng Zhang, Chao Hu, Ruiming Rong, Cheng Yang, Dong Zhu · 2021 · Frontiers in Immunology
51. The Importance of Cellular Immune Response to HIV: Implications for Antibody Production and Vaccine Design
    Elena Brenna, Andrew James McMichael · 2021 · DNA and Cell Biology
52. Comparison of renal histopathology in three patients with gross hematuria after SARS-CoV-2 vaccination
    Kento Ota, Yuriko Yonekura, Madoka Saigan, Kimihiko Goto, Shinichi Nishi · 2022 · CEN Case Reports
53. Harnessing T Follicular Helper Cell Responses for HIV Vaccine Development
    Julia Niessl, DE Kaufmann · 2018 · Viruses
54. Engineering immunity for next generation HIV vaccines: The intersection of bioengineering and immunology
    M. Patricia D’Souza, Shyam S. Rele, Barton F. Haynes, Dale J. Hu, David Lee Kaplan, Shadi Mamaghani, David M. Rampulla · 2019 · Vaccine
55. Literature Mining and Mechanistic Graphical Modelling to Improve mRNA Vaccine Platforms
    Lorena Leonardelli, Giuseppe Lofano, Gianluca Selvaggio, Silvia Parolo, Stefano Giampiccolo, Danilo Tomasoni, Enrico Domenici, Corrado Priami, Haifeng Song, Duccio Medini et al. · 2021 · Frontiers in Immunology
56. Modified mRNA-Based Vaccines Against Coronavirus Disease 2019
    Aline Yen Ling Wang · 2022 · Cell Transplantation
57. Immunogenicity of SARS-CoV-2 Trimeric Spike Protein Associated to Poly(I:C) Plus Alum
    Júlio Souza dos-Santos, Luan Firmino-Cruz, Alessandra Marcia da Fonseca-Martins, Diogo Oliveira-Maciel, G. Pérez, Victor A. R. Pereira, Carlos Henrique Dumard, Francisca Hildemagna Guedes-da-Silva, Ana C. Vicente Santos, Monique dos Santos Leandro et al. · 2022 · Frontiers in Immunology
58. Protection against SARS-CoV-2 Beta Variant in mRNA-1273 Boosted Nonhuman Primates
    Kizzmekia S. Corbett, Matthew Gagné, Danielle A. Wagner, Sarah O’ Connell, Sandeep Narpala, Dillon R. Flebbe, Shayne F. Andrew, Rachel L. Davis, Barbara J. Flynn, Timothy S. Johnston et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
59. A mRNA-LNP vaccine against Dengue Virus elicits robust, serotype-specific immunity
    Wollner, Clayton J., Richner, Michelle, Hassert, Mariah A., Pinto, Amelia K., Brien, James D., Richner, Justin M. · 2021
60. Highly pure mRNA vaccine provides robust immunization against P. aeruginosa by minimizing type I interferon responses
    Ken Kawaguchi, Le Bui Thao Nguyen, Mao Kinoshita, Naoko Abe, Makoto Oba, Hiroshi Abe, Kazuki Sudo, Keita Inoue, Satoshi Uchida, Teiji Sawa · 2025 · Journal of Controlled Release
61. Allergen-specific immunotherapy with Der p 1/2 mRNA vaccines relieves house-dust-mite-induced allergic airway inflammation in a mouse model
    Junda Li, Yi Ru, XiLian Yi, Kai Guan, Xiaogang Li, Jia Yin · 2026 · Molecular Therapy
62. Lipid nanoparticle-based non-viral in situ gene editing of congenital ichthyosis-causing mutations in human skin models
    Dilem C. Apaydin, Gaurav Sadhnani, Tiffany Carlaw, Jan Renziehausen, Elena Lizunova, Viviane Filor, Anna Luisa Hiller, Sophia Brumhard, Vincent Halim, Ulrike Brüning et al. · 2026 · Cell stem cell
63. Immunological mechanisms of mRNA vaccines for infectious diseases
    Michela Locci, Norbert Pardi · 2026 · Nature
64. Mutant and non-mutant neoantigen-based cancer vaccines: recent advances and future promises
    Mohamad Omar Ashi, Fathia Mami‐Chouaib, Stéphanie Corgnac · 2022 · Exploration of Targeted Anti-tumor Therapy
65. Phase I study of a non-S2P SARS-CoV-2 mRNA vaccine LVRNA009 in Chinese adults.
    Guifang Chen, Xuya Yu, Liping Luo, Fan Zhang, Xia-Hong Dai, Nan Li, Zhen-Wei Shen, Kai-Qi Wu, Dan Lou, Cong-Gao Peng et al. · 2023 · Vaccine
66. CD3 downregulation identifies high-avidity, multipotent SARS-CoV-2 vaccine– and recall antigen–specific Th cells with distinct metabolism
    Arne Sattler, Stefanie Gamradt, Vanessa Proß, Linda Marie Laura Thole, An He, Eva Vanessa Schrezenmeier, Katharina Jechow, Stefan Michael Gold, Soeren Lukassen, Christian Conrad et al. · 2024 · JCI Insight
67. The role of mRNA-galsomes and LNPs in enhancing HIV-specific T cell responses across various lymphoid organs
    Sigrid D’haese, Sabine den Roover, Rein Verbeke, Ilke Aernout, Sofie Meulewaeter, Joëlle Cosyns, Jessy Meert, Sarah Vanbellingen, Thessa Laeremans, Ine Lentacker et al. · 2024 · Molecular Therapy — Nucleic Acids
68. Impact of Metabolic States on SARS-CoV-2 Vaccine Responses in Mouse Models of Obesity and Diabetes
    Olivia A. Smith, B. Fujimoto, Teri Ann S. Wong, Albert To, Troy Odo, Aquena H. Ball, Brien K. Haun, Hiromi Muramatsu, Ying K. Tam, Norbert Pardi et al. · 2024 · COVID
69. Pemphigus foliaceous after mRNA COVID-19 vaccine
    Joel Reis, Miguel Nogueira, Otilia Figueiras, André Coelho, Glória Velho, Inês Raposo · 2022 · European Journal of Dermatology
70. The effect of SARS-CoV-2 BNT162b2 vaccine on the symptoms of women with endometriosis
    Adi Gilan, Sarit Laster-Haim, Amihai Rottenstreich, Shay Porat, Naama Lessans, Tal D. Saar, Uri Pinchas Dior · 2022 · Archives of Gynecology and Obstetrics
71. Guiding HIV-1 vaccine development with preclinical nonhuman primate research
    James A. Counts, Kevin O. Saunders · 2023 · Current Opinion in HIV and AIDS
72. Clinical Analysis and Applications of mRNA Vaccines in Infectious Diseases and Cancer Treatment
    Paa Kwesi Ankrah, Ajibola Olaoluwa Ilesanmi, Amos Olalekan Akinyemi, Victor Lasehinde, Oluwapelumi Eniola Adurosakin, Oluwatobi H Ajayi · 2023 · Cureus
73. CRISPR/Cas9 Editing: Sparking Discussion on Safety in Light of the Need for New Therapeutics
    Tiffany Carlaw, Linhua Zhang, Colin J. Ross · 2020 · Human Gene Therapy
74. Immunogenicity after the First Dose of the BNT162b2 mRNA COVID-19 Vaccine: Real-World Evidence from Greek Healthcare Workers
    Κωνσταντίνα Κοντοπούλου, Alexandra Ainatzoglou, Athina M. Ifantidou, Christos Theodoros Nakas, Georgia Gkounti, Eleni Antoniadou, Vasilios Adamopoulos, Nikitas Papadopoulos, Georgios Papazisis · 2021 · SSRN Electronic Journal
75. Protection from SARS-CoV-2 Delta one year after mRNA-1273 vaccination in nonhuman primates is coincident with an anamnestic antibody response in the lower airway
    Matthew Gagné, Kizzmekia S. Corbett, Barbara J. Flynn, Kathryn E. Foulds, Danielle A. Wagner, Shayne F. Andrew, John-Paul M. Todd, Christopher Cole Honeycutt, Lauren McCormick, Saule T. Nurmukhambetova et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
76. The rise of mRNA therapeutic vaccines
    Jinlu Du, Ziling Fan, Jiangming Huang, Zhengyuan Li, Haitao Hu, Yanxia Li · 2025 · RSC Pharmaceutics
77. Messenger Ribonucleic Acid (mRNA)-Based Universal Vaccines: Engineering Broad-Spectrum Immunity Against Future Pandemics
    Joan C Muodiaju, Chidinma S Madu · 2025 · Cureus
78. Emerging lipid nanoparticle systems capable of efficient intramuscular RNA delivery
    Aun Raza, Runtong Zhang, Ruonan Lu, Jingyuan Wen, Wei Wu · 2025 · Nanomedicine
79. Advances in molecular adjuvants for nucleic acid vaccines
    Casey E. Hojecki, Nicholas J. Tursi, Cory Livingston, David B. Weiner, Ebony Nicole Gary · 2025 · Frontiers in Immunology
80. An mRNA vaccine encoding the Ebola virus glycoprotein induces high neutralizing antibody titers and provides strong protection against lethal infections in mouse models
    Zachary R. Stromberg, Elvia E. Silva, Sara C. Johnston, Dylan M. Johnson, Dominique Elaine Hall, Emmanuel Adjei, John A. Altin, Abisola Abisoye-Ogunniyan, Travis R. Gollott, Wei He et al. · 2026 · Frontiers in Immunology
81. mRNA technology for the prevention and treatment of HIV-1 infection
    Chuang LIU, Alexey V. Yaremenko, Xiaolong Li, Xinru You, Xiaoyu Zhu, Nuo Liu, Wei Chen, Na Kong, Tian Xie, Gaurav D. Gaiha et al. · 2026 · Nature Reviews Bioengineering
82. mRNA-based influenza vaccine expands the B cell response breadth in humans
    Hanover C. Matz, Tae-Geun Yu, Kritika Dixit, Caroline Kikawa, Julian Q. Zhou, Garazi Peña Alzua, Lowrey Peyton, Anders Madsen, Fangjie Han, Ariana Ghez Farrell et al. · 2026 · Nature Immunology
83. Comparison of Immune Responses between Inactivated and mRNA SARS-CoV-2 Vaccines Used for a Booster Dose in Mice
    Ning Luan, Han Cao, Yunfei Wang, Kangyang Lin, Jingping Hu, Cunbao Liu · 2023 · Viruses
84. Future prospects in mRNA vaccine development
    Londiwe Simphiwe Mbatha, Jude Akinyelu, Fiona Maiyo, Tukayi Kudanga · 2023 · Biomedical Materials
85. Influence of N1-Methylpseudouridine in Guide RNAs on CRISPR/Cas9 Activity
    Daria V. Prokhorova, Anastasiya M. Matveeva, Alexander Zakabunin, Alexander Ryabchenko, Grigory A. Stepanov · 2023 · International Journal of Molecular Sciences
86. Immunization with an mRNA DTP vaccine protects against pertussis in rats
    Graham J. Bitzer, Nicholas A. Fitzgerald, Megan A. DeJong, Casey Cunningham, Joshua A. Chapman, Dylan T. Boehm, Gage Michael Pyles, Annalisa Bison Huckaby, Sarah J. Miller, Spencer R. Dublin et al. · 2024 · Infection and Immunity
87. Synthesis and Characterization of Dihydrouracil Analogs Utilizing Biginelli Hybrids
    Syed Nasir Abbas Bukhari, Hasan Ejaz, Mervat A. Elsherif, Nenad Janković · 2022 · Molecules
88. Anionic lipids modulate mRNA-lipid nanoparticle immunogenicity and confer protection in a mouse model of multiple sclerosis
    Jilian R. Melamed, Jenna Muscat-Rivera, Michael Kegel, Lesley S. Chaboub, Roxanne Perez‐Tremble, Navdeep S. Bhalla, Houping Ni, Honghong Sun, Drew Weissman · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
89. Transdermal Delivery of an mRNA‐Liposome Vaccine via Dissolving Microneedle to Preserve Vaccine Activity and Enhance Immune Activation
    Jeehye Nam, JiWon Ahn, Jiwoo Shin, Nahong Lee, Y K Lee, Sung min Cho, Paul Kim, Geonwoo Kang, Sang‐Jun Ha, Hyungil Jung · 2026 · Advanced Science
90. Decoding Undesirable Inflammatory Responses of Nucleic Acid‐Delivering Lipid Nanoparticles
    Ruimin Hu, Yin Dou, Chenwen Li, Yuying Mu, Huiying Ouyang, Wenhao Shen, Jianxiang Zhang · 2026 · Advanced Science
91. Nonstabilized SARS-CoV-2 spike mRNA vaccination induces broadly neutralizing antibodies in nonhuman primates
    Goda Baddage Rakitha Malewana, Victoria Stalls, Aaron J. May, Xiaozhi Lu, David R. Martinez, Alexandra Schäfer, Dapeng Li, Maggie Barr, Laura L. Sutherland, Esther Lee et al. · 2025 · Science Translational Medicine
92. Enhancing vaccine effectiveness in the elderly to counter antibiotic resistance: The potential of adjuvants via pattern recognition receptors
    Myunghwan Jung, Hongmin Kim, Eunsol Choi, Min‐Kyoung Shin, Sung Jae Shin · 2024 · Human Vaccines & Immunotherapeutics
93. Innate and adaptative immune mechanisms of COVID-19 vaccines. Serious adverse events associated with SARS-CoV-2 vaccination: A systematic review
    Rocío Morlanes Pallás · 2024 · Vacunas (English Edition)
94. The Safety of Anti-SARS-CoV-2 Vaccines: Vigilance Is Still Required
    Michel Goldman · 2022 · Journal of Clinical Medicine
95. Lipid Nanoparticle-Mediated Delivery of Therapeutic and Prophylactic mRNA: Immune Activation by Ionizable Cationic Lipids
    Melike Ongun, Abhijeet Girish Lokras, Camilla Foged, Aneesh Thakur · 2022 · RNA technologies
96. Übersicht über die in der EU zugelassenen COVID-19-Impfstoffe – von der Technologie über die klinische Prüfung zur Zulassung
    Eberhard Hildt · 2022 · Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz
97. Nanoformulated Single‐Stranded RNA‐Based Adjuvant with a Coordinative Amphiphile as an Effective Stabilizer: Inducing Humoral Immune Response by Activation of Antigen‐Presenting Cells
    Hyo‐Jung Park, Eun‐Kyoung Bang, Jung Joo Hong, Sang‐Myeong Lee, Hae Li Ko, Hye Won Kwak, Hye-Lim Park, Kyung Won Kang, Rhoon‐Ho Kim, Seung Rok Ryu et al. · 2020 · Angewandte Chemie
98. Ability of nucleoside-modified mRNA to encode HIV-1 envelope trimer nanoparticles
    Zekun Mu, Kevin J. Wiehe, Kevin O. Saunders, Rory C. Henderson, Derek W. Cain, Robert Parks, Diana Martik, Katayoun Mansouri, Robert J. Edwards, Amanda Newman et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
99. Chimeric hemagglutinin-based universal influenza mRNA vaccine induces protective immunity and bone marrow plasma cells in rhesus macaques
    Tiffany M. Styles, Akil Akhtar, Chunyang Gu, Gabriele Neumann, Hiromi Muramatsu, Justine S. McPartlan, Poulami Talukder, Derrik Gratz, Kasey Stokdyk, Hannah L. Turner et al. · 2025 · Cell Reports Medicine
100. mRNA-LNP vaccination orchestrates systemic immunity to control human papillomavirus-positive head and neck squamous cell carcinoma
     Ke Qiu, Minzi Mao, Yao Hua Song, Xing Duan, Yufang Rao, Lan Feng, Danni Cheng, Xiuli Shao, Yanling Liang, Chuanhuan Jiang et al. · 2025 · Molecular Therapy — Nucleic Acids